IMPROCAS - Improved Prediction of Ovarian Cancer Surgery
- Conditions
- Ovarian cancerTherapeutic area: Diseases [C] - Neoplasms [C04]Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
- Registration Number
- CTIS2023-503398-39-00
- Lead Sponsor
- Aarhus University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Suspected epithelial ovarian cancer (and referred to dept. of Gynaecology and Obstetrics, AUH, and selected for an MDT), -Understanding Danish, -Age 18 – 85 years
Contraindications for MRI with contrast: -eGFR less than 30 ml/min/1.73m2 -Significant cardiac disease such as severe left ventricular outflow obstruction -Significant obstructive lung disease or severe asthma -Pacemaker, implantable cardiac defibrillator, neurostimulator or cochlear implant -Metal foreign bodies such as fragments and irremovable piercings -Unsafe medical implants (safety of heart valves, hips and the like must be confirmed) -Claustrophobia -Largest circumference including arms > 160 cm, Substantial cognitive disability that would influence the patients’ ability to either give truly informed consent or listen to / comply with safety-related instructions., Uncontrolled diabetes or the patient presenting with a diabetic emergency such as hypoglycaemia or diabetic ketoacidosis, Severe renovascular disease, Any other malign disease or recidiv of a former malign disease present within the last 3-5 years (except benign basal basocelluar carcinoma (BBC)), Pregnancy, Allergy to pyruvate
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method